An acute-phase reactant. Increased levels are associated with normal pregnancy, rheumatoid arthritis, and cirrhosis. Decreased levels are associated with hepatolenticular degeneration (Wilson's Disease). An elevated level of Cp is found in patients with progressive tumors. Additionally, as Cp is a prooxidant, an elevated level is a sign of cardiovascular disease. Prepared from plasma shown to be non reactive for HbsAG, anti-HCV, anti-HBc, and negative for anti-HIV 1 & 2 by FDA-required tests. Handling: Following reconstitution, store at 4℃. Avoid freeze-thaw cycles, as this will contribute to protein breakdown. Exposure to sodium (in the form of sodium chloride, sodium phosphate, sodium azide, as well as other sodium containing reagents) should be avoided, as ceruloplasmin may precipitate under these conditions. Buffers that ceruloplasmin is exposed to should bepH-adjusted with potassium hydroxide.
All
Chemical Reagents
Biomedicine
Organic raw materials
Inorganic chemical industry
intermediate
Agricultural chemicals
Auxiliaries and catalysts
Fragrances and Flavors
Dyes and Pigments
Daily chemical industry
铜蓝蛋白 来源于人血浆
CAS number：unknown molecular formula：
overview
compound introduction
Specs
| Chinese alias | - | ||
| English alias | CERU_HUMAN | Ceruloplasmin | CP | CP 2 | CP2 | Ferroxidase | AB073614 | ||
| CAS number | unknown | molecular formula | |
| molecular weight | - | Exact mass | 生物活性 |
| PSA | - | logp | - |
numbering system
No numbering system information yet
physicochemical properties
No physical and chemical property information yet
Safety information
No safety information yet
Production methods and uses
No production method and use information yet
Related
upstream information
No upstream information yet
downstream information
No downstream information yet
MSDS
Found 0 shareMSDS
